Liu et al. (2021) synthesized spiropyrrolidine oxindole derivatives carrying nitroisoxazole as novel GPX4/MDM2 inhibitors inhibiting breast cancer cell proliferation. The gene discussed is GPX4; the disease is breast carcinoma.